AriBio is a clinical-stage biotech company located in Seongnam, South Korea focused on developing novel therapeutics for neurodegenerative diseases. The US office is located in San Diego managing global clinical operations and regulatory affairs. The lead asset, AR1001, is entering a global phase 3 program this year.
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | KTB Networ... | ktbnetwork... |